Fenylacetylglutamín - nový biomarker z črevného mikrobiómu v predikcii kardiovaskulárneho rizika
BackBibliographic information
- Publication year
- 2023
- Category
- V3 — Scientific output of publication activity from the journal
- CREPČ / EPCA ID
- 0041852
- Document type
- Journal article
- Source
- Lekársky obzor
- ISSN (Source)
- 0457-4214
- Volume
- Roč. 72, č. 3 (2023), s. 123-126
- Output type
- article
- Language
- Slovak
- Study field
- pharmacyField group: Health sciences and fields aimed at improving the quality of life
- Research areas
- 180 — Medical, pharmaceutical and non-medical health sciences
Bibliographic record
DUKÁT, Andrej - PAYER, Juraj - KYSELOVIČ, Ján - KOLLER, Tomáš - KRIŠKA, Milan - BERNADIČ, Marián - ŠIMKO, Fedor. Fenylacetylglutamín - nový biomarker z črevného mikrobiómu v predikcii kardiovaskulárneho rizika [he phenylacethylglutamine - a new biomarker from the intestinal microbiome and prediction of cardiovascular risk]. In: Lekársky obzor. 2023. ISSN 0457-4214, Roč. 72, č. 3 (2023), s. 123-126. (6 - H-index, 0.186 - SJR, Q4 - SJR Best Q).
Publication authors
| Author | Role | Share |
|---|---|---|
| Andrej Dukát | Author | 0.000 % |
| Juraj Payer | Author | 0.000 % |
| Ján Kyselovič | Author | 0.000 % |
| Tomáš Koller | Author | 0.000 % |
| Milan Kriška | Author | 0.000 % |
| Marián Bernadič | Author | 0.000 % |
| Fedor Šimko | Author | 0.000 % |
Metrics
SJR Q 4SJR 0.186H-index 6Metrics year 2021